TB-500

Research

Thymosin Beta-4 Fragment

Aliases
Thymosin β4, Tβ4
Administration
Subcutaneous injection, Intramuscular injection

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Some users report a subtle sense of reduced soreness or improved recovery between activity sessions.

  2. 2

    3–4 Weeks

    Range of motion and flexibility may begin to feel less limited.

  3. 3

    5–7 Weeks

    Continued use is often paired with noticeable improvements in how quickly muscles recover after exertion.

  4. 4

    8–10 Weeks

    Scar tissue-related stiffness, where present, may feel less pronounced.

  5. 5

    11–15 Weeks

    Effects tend to plateau as the loading phase transitions into a lower maintenance routine.

  6. 6

    16–20 Weeks

    Users typically report a steadier, more consistent recovery capacity by this stage.

  7. 7

    21–24 Weeks

    Long-term users often evaluate whether ongoing use still provides a noticeable benefit versus baseline.

⚠️ Research context only. This is not medical advice and results are not guaranteed.